Moreover, a radiomic signature for CD8 cells that included eight variable CD8 cell radiation signatures containing eight variables to infer clinical outcomes for patients with cancer who had been treated with anti-PD-1/PD-L1 (34). This evidence concerns the gene CD274 and cancer.